Fever Responses During Pregnancy: Clinical Implications, Mechanisms, and Management

Abstract

Fever during pregnancy is a common clinical challenge with significant implications for both maternal and fetal outcomes. This review synthesizes the latest evidence on the epidemiology, pathophysiology, risk factors, clinical manifestations, diagnostic approaches, treatment protocols, and emerging therapies relevant to febrile episodes in pregnancy. Special emphasis is placed on mechanistic insights, clinical decision-making, and guideline-based management strategies, providing a comprehensive resource for clinicians involved in maternal-fetal medicine.

Introduction

Maternal fever, defined as a body temperature exceeding 38°C (100.4°F), is a frequent presenting symptom in obstetric practice. Its occurrence during pregnancy warrants prompt evaluation due to potential adverse effects on both the mother and the developing fetus. Understanding the mechanisms, clinical implications, and management strategies of fever in pregnancy is essential for optimizing care and reducing morbidity. Recent studies underscore the need for a multidisciplinary approach that integrates obstetric, infectious disease, and neonatal expertise.

Epidemiology / Disease Burden

Fever is reported in approximately 10–15% of pregnancies, with higher rates observed in certain regions due to endemic infectious diseases. The etiology of febrile illness varies by gestational age, region, and underlying maternal health status. Common causes include urinary tract infections, chorioamnionitis, influenza, and other viral infections. Febrile morbidity and associated complications such as preterm labor, fetal loss, and congenital anomalies underscore the public health importance of effective fever management during pregnancy.

Pathophysiology

The pathophysiology of fever in pregnancy involves pyrogenic cytokines (e.g., IL-1, IL-6, TNF-α) that stimulate the hypothalamic thermoregulatory center, raising the set-point for core body temperature. Pregnancy induces immunological adaptations, including a shift towards humoral immunity and relative suppression of cell-mediated responses, increasing susceptibility to certain pathogens. The placenta also produces pyrogens and is itself a target for infection, amplifying the maternal inflammatory response. Fetal exposure to maternal hyperthermia, especially in the first trimester, may disrupt organogenesis, with neural tube defects being a documented risk.

Risk Factors

Several risk factors predispose pregnant women to febrile episodes. These include pre-existing comorbidities (diabetes, renal disease), immunosuppression, advanced maternal age, multiple gestations, and exposure to infectious agents. Socioeconomic determinants, such as access to healthcare and living conditions, further modulate risk. Obstetric interventions (e.g., prolonged rupture of membranes, invasive monitoring) can increase susceptibility to ascending infections, particularly in the intrapartum period.

Clinical Features

The clinical presentation of fever in pregnancy is often nonspecific, necessitating a high index of suspicion. Symptoms may include chills, malaise, myalgia, localized pain (e.g., flank pain in pyelonephritis), and, in severe cases, hemodynamic instability. Fetal tachycardia may be an early sign of intrauterine infection. It is critical for clinicians to distinguish between benign self-limited viral illness and severe, life-threatening infections such as sepsis or chorioamnionitis.

Diagnosis

Diagnostic evaluation of fever in pregnancy should be rapid and thorough, aiming to identify the underlying etiology and assess fetal well-being. Investigations include complete blood count, urinalysis and urine culture, blood cultures, chest radiography (with abdominal shielding), and targeted serologies or PCR assays based on clinical suspicion. Ultrasonography is valuable for detecting intrauterine infection or fetal distress. Amniocentesis may be indicated in select cases for microbiological assessment of amniotic fluid.

Treatment & Management

Management strategies should be individualized based on gestational age, severity of illness, and suspected etiology. Empiric antibiotic therapy is warranted in cases of suspected bacterial infection, with regimen selection guided by local resistance patterns and safety profiles during pregnancy. Supportive care includes antipyretics (preferably acetaminophen), intravenous fluids, and close fetal monitoring. In severe cases, hospitalization and multidisciplinary management are indicated. Maternal hyperthermia should be promptly treated to reduce the risk of adverse fetal outcomes.

Recent Advances / Emerging Therapies

Recent advances in diagnostic technology, such as rapid molecular assays and point-of-care testing, have improved the speed and accuracy of pathogen identification. Novel therapeutic approaches, including targeted immunomodulatory therapies and next-generation antimicrobials, are being explored, particularly for resistant and atypical pathogens. There is growing interest in the role of maternal vaccination (e.g., influenza, COVID-19) in reducing the incidence and severity of febrile illness during pregnancy. Telemedicine platforms are increasingly used for triage and follow-up, improving access to care in underserved populations.

Guideline Recommendations

Current guidelines from organizations such as the American College of Obstetricians and Gynecologists (ACOG) and the Centers for Disease Control and Prevention (CDC) emphasize the importance of early recognition and treatment of fever in pregnancy. Key recommendations include prompt initiation of empiric therapy for suspected serious infection, avoidance of contraindicated medications (e.g., NSAIDs in the third trimester), and routine vaccination as part of prenatal care. Fetal monitoring and consideration of delivery in cases of refractory maternal sepsis are also highlighted. Multidisciplinary collaboration is essential to optimize outcomes.

Conclusion

Fever during pregnancy represents a complex clinical entity requiring vigilant assessment, timely intervention, and adherence to evidence-based guidelines. Advances in diagnostics and therapeutics are enhancing the ability to manage febrile illnesses effectively, minimizing risks to both mother and fetus. Continued research and education are needed to address evolving epidemiological trends and improve maternal-fetal health across diverse populations.